{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:42:56Z","timestamp":1775047376186,"version":"3.50.1"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Alan Turing Institute\/Engineering and Physical Sciences Research Council","award":["EP\/N510129\/1"],"award-info":[{"award-number":["EP\/N510129\/1"]}]},{"name":"the Alan Turing Institute\/Engineering and Physical Sciences Research Council","award":["EP\/N510129\/1"],"award-info":[{"award-number":["EP\/N510129\/1"]}]},{"name":"the Alan Turing Institute\/Engineering and Physical Sciences Research Council","award":["EP\/N510129\/1"],"award-info":[{"award-number":["EP\/N510129\/1"]}]},{"name":"George Moore Endowment for Data Science at Ulster University"},{"name":"UKRI Future Leaders Fellowship","award":["MR\/S03546X\/1"],"award-info":[{"award-number":["MR\/S03546X\/1"]}]},{"name":"The Motor Neurone Disease Association (MNDA) Fellowship","award":["Al Khleifat\/Oct21\/975-799"],"award-info":[{"award-number":["Al Khleifat\/Oct21\/975-799"]}]},{"name":"ALS Association Milton Safenowitz Research Fellowship"},{"name":"George Henry Woolfe Legacy Fund"},{"name":"National Institute for Health Research (NIHR) Applied Research Collaboration (ARC) South West Peninsula"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute on Aging\/National Institutes of Health","award":["RF1AG055654"],"award-info":[{"award-number":["RF1AG055654"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Inf."],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Progress in dementia research has been limited, with substantial gaps in our knowledge of targets for prevention, mechanisms for disease progression, and disease-modifying treatments. The growing availability of multimodal data sets opens possibilities for the application of machine learning and artificial intelligence (AI) to help answer key questions in the field. We provide an overview of the state of the science, highlighting current challenges and opportunities for utilisation of AI approaches to move the field forward in the areas of genetics, experimental medicine, drug discovery and trials optimisation, imaging, and prevention. Machine learning methods can enhance results of genetic studies, help determine biological effects and facilitate the identification of drug targets based on genetic and transcriptomic information. The use of unsupervised learning for understanding disease mechanisms for drug discovery is promising, while analysis of multimodal data sets to characterise and quantify disease severity and subtype are also beginning to contribute to optimisation of clinical trial recruitment. Data-driven experimental medicine is needed to analyse data across modalities and develop novel algorithms to translate insights from animal models to human disease biology. AI methods in neuroimaging outperform traditional approaches for diagnostic classification, and although challenges around validation and translation remain, there is optimism for their meaningful integration to clinical practice in the near future. AI-based models can also clarify our understanding of the causality and commonality of dementia risk factors, informing and improving risk prediction models along with the development of preventative interventions. The complexity and heterogeneity of dementia requires an alternative approach beyond traditional design and analytical approaches. Although not yet widely used in dementia research, machine learning and AI have the potential to unlock current challenges and advance precision dementia medicine.<\/jats:p>","DOI":"10.1186\/s40708-022-00183-3","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T18:03:02Z","timestamp":1677261782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Harnessing the potential of machine learning and artificial intelligence for dementia research"],"prefix":"10.1186","volume":"10","author":[{"given":"Janice M.","family":"Ranson","sequence":"first","affiliation":[]},{"given":"Magda","family":"Bucholc","sequence":"additional","affiliation":[]},{"given":"Donald","family":"Lyall","sequence":"additional","affiliation":[]},{"given":"Danielle","family":"Newby","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Winchester","sequence":"additional","affiliation":[]},{"given":"Neil P.","family":"Oxtoby","sequence":"additional","affiliation":[]},{"given":"Michele","family":"Veldsman","sequence":"additional","affiliation":[]},{"given":"Timothy","family":"Rittman","sequence":"additional","affiliation":[]},{"given":"Sarah","family":"Marzi","sequence":"additional","affiliation":[]},{"given":"Nathan","family":"Skene","sequence":"additional","affiliation":[]},{"given":"Ahmad","family":"Al Khleifat","sequence":"additional","affiliation":[]},{"given":"Isabelle F.","family":"Foote","sequence":"additional","affiliation":[]},{"given":"Vasiliki","family":"Orgeta","sequence":"additional","affiliation":[]},{"given":"Andrey","family":"Kormilitzin","sequence":"additional","affiliation":[]},{"given":"Ilianna","family":"Lourida","sequence":"additional","affiliation":[]},{"given":"David J.","family":"Llewellyn","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"key":"183_CR1","unstructured":"Alzheimer\u2019s Association. What Is Dementia? https:\/\/www.alz.org\/alzheimers-dementia\/what-is-dementia. Accessed 16 Feb 2019."},{"key":"183_CR2","unstructured":"Wightman DP, Jansen IE, Savage JE, et al. Largest GWAS (N=1,126,563) of Alzheimer\u2019s Disease Implicates Microglia and Immune Cells. medRxiv 2020:2020.2011.2020.20235275."},{"key":"183_CR3","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ng.3404","volume":"47","author":"HK Finucane","year":"2015","unstructured":"Finucane HK, Bulik-Sullivan B, Gusev A et al (2015) Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat Genet 47:1228\u20131235","journal-title":"Nat Genet"},{"key":"183_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004219","volume":"11","author":"CA de Leeuw","year":"2015","unstructured":"de Leeuw CA, Mooij JM, Heskes T, Posthuma D (2015) MAGMA: Generalized Gene-Set Analysis of GWAS Data. PLoS Comput Biol 11:e1004219","journal-title":"PLoS Comput Biol"},{"key":"183_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/braincomms\/fcac125","volume":"4","author":"V Escott-Price","year":"2022","unstructured":"Escott-Price V, Hardy J (2022) Genome-wide association studies for Alzheimer\u2019s disease: bigger is not always better. Brain Commun 4:8","journal-title":"Brain Commun"},{"key":"183_CR6","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/s41588-020-00735-5","volume":"52","author":"O Weissbrod","year":"2020","unstructured":"Weissbrod O, Hormozdiari F, Benner C et al (2020) Functionally informed fine-mapping and polygenic localization of complex trait heritability. Nat Genet 52:1355\u20131363","journal-title":"Nat Genet"},{"key":"183_CR7","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1038\/s41467-021-23134-8","volume":"12","author":"QS Wang","year":"2021","unstructured":"Wang QS, Kelley DR, Ulirsch J et al (2021) Leveraging supervised learning for functionally informed fine-mapping of cis-eQTLs identifies an additional 20,913 putative causal eQTLs. Nat Commun 12:3394","journal-title":"Nat Commun"},{"key":"183_CR8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41587-019-0140-0","volume":"37","author":"\u017d Avsec","year":"2019","unstructured":"Avsec \u017d, Kreuzhuber R, Israeli J et al (2019) The Kipoi repository accelerates community exchange and reuse of predictive models for genomics. Nat Biotechnol 37:592\u2013600","journal-title":"Nat Biotechnol"},{"key":"183_CR9","doi-asserted-by":"crossref","unstructured":"Avsec \u017d, Agarwal V, Visentin D, et al. Effective gene expression prediction from sequence by integrating long-range interactions. bioRxiv 2021:2021.2004.2007.438649.","DOI":"10.1101\/2021.04.07.438649"},{"key":"183_CR10","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1093\/bioinformatics\/bty364","volume":"34","author":"X Pan","year":"2018","unstructured":"Pan X, Shen H-B (2018) Predicting RNA\u2013protein binding sites and motifs through combining local and global deep convolutional neural networks. Bioinformatics 34:3427\u20133436","journal-title":"Bioinformatics"},{"key":"183_CR11","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1261\/rna.066290.118","volume":"24","author":"JM Paggi","year":"2018","unstructured":"Paggi JM, Bejerano G (2018) A sequence-based, deep learning model accurately predicts RNA splicing branchpoints. RNA 24:1647\u20131658","journal-title":"RNA"},{"key":"183_CR12","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/s41592-020-0960-3","volume":"17","author":"R Schwessinger","year":"2020","unstructured":"Schwessinger R, Gosden M, Downes D et al (2020) DeepC: predicting 3D genome folding using megabase-scale transfer learning. Nat Methods 17:1118\u20131124","journal-title":"Nat Methods"},{"key":"183_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008489","volume":"15","author":"EA King","year":"2019","unstructured":"King EA, Davis JW, Degner JF (2019) Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS Genet 15:e1008489","journal-title":"PLoS Genet"},{"key":"183_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajhg.2017.06.005","volume":"101","author":"PM Visscher","year":"2017","unstructured":"Visscher PM, Wray NR, Zhang Q et al (2017) 10 Years of GWAS discovery: biology, function, and translation. Am J Hum Genet 101:5\u201322","journal-title":"Am J Hum Genet"},{"key":"183_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13073-020-00742-5","volume":"12","author":"CM Lewis","year":"2020","unstructured":"Lewis CM, Vassos E (2020) Polygenic risk scores: from research tools to clinical instruments. Genome Med 12:44","journal-title":"Genome Med"},{"key":"183_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/s41582-020-0377-8","volume":"16","author":"MA Myszczynska","year":"2020","unstructured":"Myszczynska MA, Ojamies PN, Lacoste AMB et al (2020) Applications of machine learning to diagnosis and treatment of neurodegenerative diseases. Nat Rev Neurol 16:440\u2013456","journal-title":"Nat Rev Neurol"},{"key":"183_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/braincomms\/fcab246","volume":"3","author":"TW Rowe","year":"2021","unstructured":"Rowe TW, Katzourou IK, Stevenson-Hoare JO, Bracher-Smith MR, Ivanov DK, Escott-Price V (2021) Machine learning for the life-time risk prediction of Alzheimer\u2019s disease: a systematic review. Brain Communications 3:7","journal-title":"Brain Communications"},{"key":"183_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S2213-8587(16)30396-5","volume":"5","author":"AF Schmidt","year":"2017","unstructured":"Schmidt AF, Swerdlow DI, Holmes MV et al (2017) PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol 5:97\u2013105","journal-title":"Lancet Diabetes Endocrinol"},{"key":"183_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41436-020-0905-3","volume":"22","author":"C Hoell","year":"2020","unstructured":"Hoell C, Wynn J, Rasmussen L et al (2020) Participant choices for return of genomic results in the eMERGE Network. Genetics Med 22:7","journal-title":"Genetics Med"},{"key":"183_CR20","doi-asserted-by":"publisher","first-page":"e2691","DOI":"10.1212\/WNL.0000000000007551","volume":"92","author":"DM Lyall","year":"2019","unstructured":"Lyall DM, Celis-Morales C, Lyall LM et al (2019) Assessing for interaction between APOE \u03b54, sex, and lifestyle on cognitive abilities. Neurology 92:e2691\u2013e2698","journal-title":"Neurology"},{"key":"183_CR21","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jamaneurol.2017.4365","volume":"75","author":"A Solomon","year":"2018","unstructured":"Solomon A, Turunen H, Ngandu T et al (2018) Effect of the Apolipoprotein E genotype on cognitive change during a multidomain lifestyle intervention: a subgroup analysis of a randomized clinical trial. JAMA Neurol 75:462\u2013470","journal-title":"JAMA Neurol"},{"key":"183_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1532-5415.2011.03768.x","volume":"60","author":"RP Gelber","year":"2012","unstructured":"Gelber RP, Petrovitch H, Masaki KH et al (2012) Lifestyle and the risk of dementia in Japanese-american men. J Am Geriatr Soc 60:118\u2013123","journal-title":"J Am Geriatr Soc"},{"key":"183_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1001\/jama.2019.9879","volume":"322","author":"I Lourida","year":"2019","unstructured":"Lourida I, Hannon E, Littlejohns TJ et al (2019) Association of lifestyle and genetic risk with incidence of dementia. JAMA 322:430\u2013437","journal-title":"JAMA"},{"key":"183_CR24","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41591-019-0547-7","volume":"25","author":"S Licher","year":"2019","unstructured":"Licher S, Ahmad S, Karamuji\u0107-\u010comi\u0107 H et al (2019) Genetic predisposition, modifiable-risk-factor profile and long-term dementia risk in the general population. Nat Med 25:1364\u20131369","journal-title":"Nat Med"},{"key":"183_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.dadm.2018.05.006","volume":"10","author":"DL McCartney","year":"2018","unstructured":"McCartney DL, Stevenson AJ, Walker RM et al (2018) Investigating the relationship between DNA methylation age acceleration and risk factors for Alzheimer\u2019s disease. Alzheimers Dement (Amst) 10:429\u2013437","journal-title":"Alzheimers Dement (Amst)"},{"key":"183_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fnagi.2022.838436","volume":"14","author":"KE Foley","year":"2022","unstructured":"Foley KE, Hewes AA, Garceau DT et al (2022) The APOE\u03b53\/\u03b54 Genotype Drives Distinct Gene Signatures in the Cortex of Young Mice. Front Aging Neurosci 14:89","journal-title":"Front Aging Neurosci"},{"key":"183_CR27","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/s41596-020-00472-3","volume":"16","author":"A Nott","year":"2021","unstructured":"Nott A, Schlachetzki JCM, Fixsen BR, Glass CK (2021) Nuclei isolation of multiple brain cell types for omics interrogation. Nat Protoc 16:1629\u20131646","journal-title":"Nat Protoc"},{"key":"183_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2021.12.008","volume":"29","author":"E Giacomelli","year":"2022","unstructured":"Giacomelli E, Vahsen BF, Calder EL et al (2022) Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation. Cell Stem Cell 29:11\u201335","journal-title":"Cell Stem Cell"},{"key":"183_CR29","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41380-019-0500-7","volume":"25","author":"K Grenier","year":"2020","unstructured":"Grenier K, Kao J, Diamandis P (2020) Three-dimensional modeling of human neurodegeneration: brain organoids coming of age. Mol Psychiatry 25:254\u2013274","journal-title":"Mol Psychiatry"},{"key":"183_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12987-020-00179-3","volume":"17","author":"A Gerhartl","year":"2020","unstructured":"Gerhartl A, Pracser N, Vladetic A, Hendrikx S, Friedl HP, Neuhaus W (2020) The pivotal role of micro-environmental cells in a human blood-brain barrier in vitro model of cerebral ischemia: functional and transcriptomic analysis. Fluids Barriers CNS 17:19","journal-title":"Fluids Barriers CNS"},{"key":"183_CR31","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1038\/s41593-019-0525-x","volume":"22","author":"R Mancuso","year":"2019","unstructured":"Mancuso R, Van Den Daele J, Fattorelli N et al (2019) Stem-cell-derived human microglia transplanted in mouse brain to study human disease. Nat Neurosci 22:2111\u20132116","journal-title":"Nat Neurosci"},{"key":"183_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13024-021-00473-0","volume":"16","author":"C Claes","year":"2021","unstructured":"Claes C, Danhash EP, Hasselmann J et al (2021) Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer\u2019s disease. Mol Neurodegener 16:50","journal-title":"Mol Neurodegener"},{"key":"183_CR33","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.tins.2022.06.007","volume":"45","author":"E D\u2019Angelo","year":"2022","unstructured":"D\u2019Angelo E, Jirsa V (2022) The quest for multiscale brain modeling. Trends Neurosci 45:777\u2013790","journal-title":"Trends Neurosci"},{"key":"183_CR34","doi-asserted-by":"crossref","unstructured":"Amunts K, Institute of Neurosciences and Medicine (INM-1) RCJ, Germany; C. & O. Vogt Institute for Brain Research, University Hospital D\u00fcsseldorf, Heinrich-Heine University D\u00fcsseldorf, Germany, ; Axer MB, Lise; Bjaalie, Jan; Brovelli, Andrea; Caspers, Svenja; Changeux, Jean-Pierre; Costantini, Irene; D'Angelo, Egidio; De Bonis, Giulia; Deco, Gustavo; DeFelipe, Javier; Destexhe, Alain; Dickscheid, Timo; Diesmann, Markus; Duqu\u00e9, Julie; D\u00fczel, Emrah; Eickhoff, Simon B.; Engel, Andreas K.; Evers, Kathinka; Fousek, Jan; Furber, Stephen; Goebel, Rainer; G\u00fcnt\u00fcrk\u00fcn, Onur; De Kerchove d'Exaerde, Alban; Hellgren Kotaleski, Jeanette; Krsnik, Zeljka; Hilgetag, Claus C.; H\u00f6lter, Sabine M.; Ioannidis, Yannis; Jirsa, Viktor; Klijn, Wouter; K\u00e4mpfer, Julia; Lippert, Thomas; Maquet, Pierre; Marinazzo, Daniele; Meyer-Lindenberg, Andreas; Migliore, Michele; Morel, Yannick; Morin, Fabrice; Nagels, Guy; Oden, Lena; Panagiotaropoulos, Fanis; Paolucci, Pier Stanislao; Pennartz, Cyriel; Peeters, Liesbet M.; Petkoski, Spase; Petrovici, Mihai A.; Roelfsema, Pieter; Ris, Laurence; Ritter, Petra; Rotter, Stefan; Rowald, Andreas; Ruland, Sabine; Ryvlin, Philippe; Salles, Arleen; Sanchez-Vives, Maria V.; Schemmel, Johannes; Thirion, Betrand; Van Albada, Sacha Jennifer; Vanduffel, Wim; De Vos, Winnok. The coming decade of digital brain research - A vision for neuroscience at the intersection of technology and computing (Version 2.0). . Zenodo 2022.","DOI":"10.1162\/imag_a_00137"},{"key":"183_CR35","first-page":"5","volume":"78","author":"CL Hartl","year":"2021","unstructured":"Hartl CL, Ramaswami G, Pembroke WG et al (2021) Coexpression network architecture reveals the brain-wide and multiregional basis of disease susceptibility. Nat Neurosci 78:5","journal-title":"Nat Neurosci"},{"key":"183_CR36","doi-asserted-by":"publisher","first-page":"e4290","DOI":"10.1126\/science.abl4290","volume":"376","author":"G Eraslan","year":"2022","unstructured":"Eraslan G, Drokhlyansky E, Anand S et al (2022) Single-nucleus cross-tissue molecular reference maps toward understanding disease gene function. Science 376:e4290","journal-title":"Science"},{"key":"183_CR37","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/bioinformatics\/btu611","volume":"31","author":"K Rhrissorrakrai","year":"2015","unstructured":"Rhrissorrakrai K, Belcastro V, Bilal E et al (2015) Understanding the limits of animal models as predictors of human biology: lessons learned from the sbv IMPROVER Species Translation Challenge. Bioinformatics 31:471\u2013483","journal-title":"Bioinformatics"},{"key":"183_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1136\/bmj.39048.407928.BE","volume":"334","author":"P Perel","year":"2007","unstructured":"Perel P, Roberts I, Sena E et al (2007) Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ (Clinical research ed) 334:197\u2013197","journal-title":"BMJ (Clinical research ed)"},{"key":"183_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.trci.2016.06.002","volume":"2","author":"J Ferrero","year":"2016","unstructured":"Ferrero J, Williams L, Stella H et al (2016) First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer\u2019s disease. Alzheimers Dement (N Y) 2:169\u2013176","journal-title":"Alzheimers Dement (N Y)"},{"key":"183_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1682","volume":"374","author":"S Walsh","year":"2021","unstructured":"Walsh S, Merrick R, Milne R, Brayne C (2021) Aducanumab for Alzheimer\u2019s disease? BMJ 374:n1682","journal-title":"BMJ"},{"key":"183_CR41","first-page":"197","volume":"9","author":"S Budd Haeberlein","year":"2022","unstructured":"Budd Haeberlein S, Aisen PS, Barkhof F et al (2022) Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s Disease. J Prev Alzheimer\u2019s Dis 9:197\u2013210","journal-title":"J Prev Alzheimer's Dis"},{"key":"183_CR42","doi-asserted-by":"crossref","unstructured":"The Lancet Digital H. Guiding better design and reporting of AI-intervention trials. Lancet Digit Health 2020;2:e493.","DOI":"10.1016\/S2589-7500(20)30223-5"},{"key":"183_CR43","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.tips.2019.05.005","volume":"40","author":"S Harrer","year":"2019","unstructured":"Harrer S, Shah P, Antony B, Hu J (2019) Artificial intelligence for clinical trial design. Trends Pharmacol Sci 40:577\u2013591","journal-title":"Trends Pharmacol Sci"},{"key":"183_CR44","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s12859-019-3101-1","volume":"20","author":"R Karki","year":"2019","unstructured":"Karki R, Kodamullil AT, Hoyt CT, Hofmann-Apitius M (2019) Quantifying mechanisms in neurodegenerative diseases (NDDs) using candidate mechanism perturbation amplitude (CMPA) algorithm. BMC Bioinformatics 20:494","journal-title":"BMC Bioinformatics"},{"key":"183_CR45","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jalz.2015.02.006","volume":"11","author":"AT Kodamullil","year":"2015","unstructured":"Kodamullil AT, Younesi E, Naz M, Bagewadi S, Hofmann-Apitius M (2015) Computable cause-and-effect models of healthy and Alzheimer\u2019s disease states and their mechanistic differential analysis. Alzheimers Dement 11:1329\u20131339","journal-title":"Alzheimers Dement"},{"key":"183_CR46","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1093\/bioinformatics\/btx399","volume":"33","author":"D Domingo-Fern\u00e1ndez","year":"2017","unstructured":"Domingo-Fern\u00e1ndez D, Kodamullil AT, Iyappan A et al (2017) Multimodal mechanistic signatures for neurodegenerative diseases (NeuroMMSig): a web server for mechanism enrichment. Bioinformatics 33:3679\u20133681","journal-title":"Bioinformatics"},{"key":"183_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pharep.2015.07.006","volume":"68","author":"J Gody\u0144","year":"2016","unstructured":"Gody\u0144 J, Jo\u0144czyk J, Panek D, Malawska B (2016) Therapeutic strategies for Alzheimer\u2019s disease in clinical trials. Pharmacol Rep 68:127\u2013138","journal-title":"Pharmacol Rep"},{"key":"183_CR48","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fpubh.2018.00181","volume":"6","author":"J Ryan","year":"2018","unstructured":"Ryan J, Fransquet P, Wrigglesworth J, Lacaze P (2018) Phenotypic heterogeneity in dementia: a challenge for epidemiology and biomarker studies. Front Public Health 6:181","journal-title":"Front Public Health"},{"key":"183_CR49","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1212\/WNL.0000000000011774","volume":"96","author":"LG Friedman","year":"2021","unstructured":"Friedman LG, McKeehan N, Hara Y et al (2021) Value-generating exploratory trials in neurodegenerative dementias. Neurology 96:944\u2013954","journal-title":"Neurology"},{"key":"183_CR50","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00401-020-02195-x","volume":"140","author":"J Lantero Rodriguez","year":"2020","unstructured":"Lantero Rodriguez J, Karikari TK, Su\u00e1rez-Calvet M et al (2020) Plasma p-tau181 accurately predicts Alzheimer\u2019s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline. Acta Neuropathol 140:267\u2013278","journal-title":"Acta Neuropathol"},{"key":"183_CR51","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","volume":"12","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, Janelidze S, Al Khleifat A et al (2021) A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat Commun 12:3400","journal-title":"Nat Commun"},{"key":"183_CR52","first-page":"48","volume":"8","author":"MS Rafii","year":"2021","unstructured":"Rafii MS, Zaman S, Handen BL (2021) Integrating Biomarker Outcomes into Clinical Trials for Alzheimer\u2019s Disease in Down Syndrome. J Prev Alzheimers Dis 8:48\u201351","journal-title":"J Prev Alzheimers Dis"},{"key":"183_CR53","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack Jr","year":"2016","unstructured":"Jack CR Jr, Bennett DA, Blennow K et al (2016) A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87:539\u2013547","journal-title":"Neurology"},{"key":"183_CR54","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13195-020-00695-2","volume":"12","author":"A O'Connor","year":"2020","unstructured":"O\u2019Connor A, Weston PSJ, Pavisic IM et al (2020) Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer\u2019s disease: a retrospective cohort analysis. Alzheimers Res Ther 12:126","journal-title":"Alzheimers Res Ther"},{"key":"183_CR55","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1474-4422(17)30434-9","volume":"17","author":"PSJ Weston","year":"2018","unstructured":"Weston PSJ, Nicholas JM, Henley SMD et al (2018) Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer\u2019s disease: a cross-sectional study. Lancet neurol 17:123\u2013132","journal-title":"Lancet neurol"},{"key":"183_CR56","doi-asserted-by":"publisher","first-page":"652","DOI":"10.4088\/JCP.13m08927","volume":"75","author":"N Ayutyanont","year":"2014","unstructured":"Ayutyanont N, Langbaum JB, Hendrix SB et al (2014) The Alzheimer\u2019s prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer\u2019s disease treatments in presenilin 1 E280A mutation carriers. J Clin Psychiatry 75:652\u2013660","journal-title":"J Clin Psychiatry"},{"key":"183_CR57","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/jnc.15023","volume":"155","author":"S Bullain","year":"2020","unstructured":"Bullain S, Doody R (2020) What works and what does not work in Alzheimer\u2019s disease? From interventions on risk factors to anti-amyloid trials. J Neurochem 155:120\u2013136","journal-title":"J Neurochem"},{"key":"183_CR58","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","volume":"27","author":"JW Vogel","year":"2021","unstructured":"Vogel JW, Young AL, Oxtoby NP et al (2021) Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease. Nat Med 27:871\u2013881","journal-title":"Nat Med"},{"key":"183_CR59","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/WCO.0000000000000460","volume":"30","author":"NP Oxtoby","year":"2017","unstructured":"Oxtoby NP, Alexander DC (2017) Imaging plus X: multimodal models of neurodegenerative disease. Curr Opin Neurol 30:371\u2013379","journal-title":"Curr Opin Neurol"},{"key":"183_CR60","doi-asserted-by":"crossref","unstructured":"Golriz K S, Robinson C, Birkenbihl C, Domingo-Fern\u00e1ndez D, Hoyt CT, Hofmann-Apitius M. Challenges of Integrative Disease Modeling in Alzheimer's Disease. Front Mol Biosci 2020;6.","DOI":"10.3389\/fmolb.2019.00158"},{"key":"183_CR61","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1038\/s41467-018-05892-0","volume":"9","author":"AL Young","year":"2018","unstructured":"Young AL, Marinescu RV, Oxtoby NP et al (2018) Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nat Commun 9:4273","journal-title":"Nat Commun"},{"key":"183_CR62","volume":"6","author":"ER Hascup","year":"2020","unstructured":"Hascup ER, Hascup KN (2020) Toward refining Alzheimer\u2019s disease into overlapping subgroups. Alzheimers Dement (N Y) 6:e12070","journal-title":"Alzheimers Dement (N Y)"},{"key":"183_CR63","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/frai.2022.660581","volume":"5","author":"NP Oxtoby","year":"2022","unstructured":"Oxtoby NP, Shand C, Cash DM, Alexander DC, Barkhof F (2022) Targeted Screening for Alzheimer\u2019s Disease Clinical Trials Using Data-Driven Disease Progression Models. Front Artif Intell 5:34","journal-title":"Front Artif Intell"},{"key":"183_CR64","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/bmb\/ldw058","volume":"121","author":"I Brassington","year":"2017","unstructured":"Brassington I (2017) The ethics of reporting all the results of clinical trials. Br Med Bull 121:19\u201329","journal-title":"Br Med Bull"},{"key":"183_CR65","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.medcli.2012.06.009","volume":"139","author":"C P\u00e9rez-Ma\u00f1\u00e1","year":"2012","unstructured":"P\u00e9rez-Ma\u00f1\u00e1 C, Llonch C, Farr\u00e9 M (2012) Transparency in clinical research: registration of clinical trials and publication of results. Med Clin (Barc) 139:593\u2013597","journal-title":"Med Clin (Barc)"},{"issue":"Suppl 1","key":"183_CR66","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/jnc.13640","volume":"138","author":"RM Tsai","year":"2016","unstructured":"Tsai RM, Boxer AL (2016) Therapy and clinical trials in frontotemporal dementia: past, present, and future. J Neurochem 138(Suppl 1):211\u2013221","journal-title":"J Neurochem"},{"key":"183_CR67","unstructured":"Marinescu R, Oxtoby N, Young A, et al. The Alzheimer's Disease Prediction Of Longitudinal Evolution (TADPOLE) Challenge: Results after 1 Year Follow-up2020."},{"key":"183_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2020.103429","volume":"107","author":"SM Goodday","year":"2020","unstructured":"Goodday SM, Kormilitzin A, Vaci N et al (2020) Maximizing the use of social and behavioural information from secondary care mental health electronic health records. J Biomed Inform 107:103429","journal-title":"J Biomed Inform"},{"key":"183_CR69","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1073\/pnas.0308627101","volume":"101","author":"MD Greicius","year":"2004","unstructured":"Greicius MD, Srivastava G, Reiss AL, Menon V (2004) Default-mode network activity distinguishes Alzheimer\u2019s disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A 101:4637\u20134642","journal-title":"Proc Natl Acad Sci U S A"},{"key":"183_CR70","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2741\/4587","volume":"23","author":"A Horvath","year":"2018","unstructured":"Horvath A, Szucs A, Csukly G, Sakovics A, Stefanics G, Kamondi A (2018) EEG and ERP biomarkers of Alzheimer\u2019s disease: a critical review. Front Biosci (Landmark Ed) 23:183\u2013220","journal-title":"Front Biosci (Landmark Ed)"},{"key":"183_CR71","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jns.2009.08.028","volume":"289","author":"CJ Stam","year":"2010","unstructured":"Stam CJ (2010) Use of magnetoencephalography (MEG) to study functional brain networks in neurodegenerative disorders. J Neurol Sci 289:128\u2013134","journal-title":"J Neurol Sci"},{"key":"183_CR72","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neurobiolaging.2019.09.008","volume":"85","author":"C Babiloni","year":"2020","unstructured":"Babiloni C, Blinowska K, Bonanni L et al (2020) What electrophysiology tells us about Alzheimer\u2019s disease: a window into the synchronization and connectivity of brain neurons. Neurobiol Aging 85:58\u201373","journal-title":"Neurobiol Aging"},{"key":"183_CR73","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","volume":"19","author":"G Ch\u00e9telat","year":"2020","unstructured":"Ch\u00e9telat G, Arbizu J, Barthel H et al (2020) Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer\u2019s disease and other dementias. Lancet Neurol 19:951\u2013962","journal-title":"Lancet Neurol"},{"key":"183_CR74","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A et al (2004) Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann Neurol 55:306\u2013319","journal-title":"Ann Neurol"},{"key":"183_CR75","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","volume":"4","author":"VJ Lowe","year":"2016","unstructured":"Lowe VJ, Curran G, Fang P et al (2016) An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol Commun 4:58","journal-title":"Acta Neuropathol Commun"},{"key":"183_CR76","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/jmri.21049","volume":"27","author":"CR Jack Jr","year":"2008","unstructured":"Jack CR Jr, Bernstein MA, Fox NC et al (2008) The Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 27:685\u2013691","journal-title":"J Magn Reson Imaging"},{"key":"183_CR77","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/WAD.0b013e318142774e","volume":"21","author":"DL Beekly","year":"2007","unstructured":"Beekly DL, Ramos EM, Lee WW et al (2007) The National Alzheimer\u2019s Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Dis Assoc Disord 21:249\u2013258","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"183_CR78","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1162\/jocn.2007.19.9.1498","volume":"19","author":"DS Marcus","year":"2007","unstructured":"Marcus DS, Wang TH, Parker J, Csernansky JG, Morris JC, Buckner RL (2007) Open Access Series of Imaging Studies (OASIS): Cross-sectional MRI data in young, middle aged, nondemented, and demented older adults. J Cogn Neurosci 19:1498\u20131507","journal-title":"J Cogn Neurosci"},{"key":"183_CR79","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1474-4422(14)70324-2","volume":"14","author":"JD Rohrer","year":"2015","unstructured":"Rohrer JD, Nicholas JM, Cash DM et al (2015) Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative ( GENFI ) study\u202f: a cross-sectional analysis. Lancet Neurol 14:253\u2013262","journal-title":"Lancet Neurol"},{"key":"183_CR80","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10654-020-00633-4","volume":"35","author":"S Bauermeister","year":"2020","unstructured":"Bauermeister S, Orton C, Thompson S et al (2020) The Dementias Platform UK (DPUK) Data Portal. Eur J Epidemiol 35:601\u2013611","journal-title":"Eur J Epidemiol"},{"key":"183_CR81","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jneumeth.2019.05.006","volume":"323","author":"F Li","year":"2019","unstructured":"Li F, Liu M (2019) A hybrid convolutional and recurrent neural network for hippocampus analysis in Alzheimer\u2019s Disease. J Neurosci Methods 323:108\u2013118","journal-title":"J Neurosci Methods"},{"key":"183_CR82","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3233\/JAD-190594","volume":"74","author":"A Morin","year":"2020","unstructured":"Morin A, Samper-Gonzalez J, Bertrand A et al (2020) Accuracy of MRI Classification Algorithms in a Tertiary Memory Center Clinical Routine Cohort. J Alzheimers Dis 74:1157\u20131166","journal-title":"J Alzheimers Dis"},{"key":"183_CR83","doi-asserted-by":"crossref","unstructured":"Giorgio J, Landau S, Jagust W, Tino P, Kourtzi Z. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease. NeuroImage: Clinical 2020.","DOI":"10.1016\/j.nicl.2020.102199"},{"key":"183_CR84","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1038\/s41467-022-28795-7","volume":"13","author":"J Giorgio","year":"2022","unstructured":"Giorgio J, Jagust WJ, Baker S et al (2022) A robust and interpretable machine learning approach using multimodal biological data to predict future pathological tau accumulation. Nat Commun 13:1887","journal-title":"Nat Commun"},{"key":"183_CR85","doi-asserted-by":"crossref","unstructured":"Borchert R, Azevedo T, Badhwar A, et al. Artificial intelligence for diagnosis and prognosis in neuroimaging for dementia; a systematic review. medRxiv 2021:2021.2012.2012.21267677.","DOI":"10.1101\/2021.12.12.21267677"},{"key":"183_CR86","doi-asserted-by":"publisher","first-page":"11934","DOI":"10.1038\/ncomms11934","volume":"7","author":"Y Iturria-Medina","year":"2016","unstructured":"Iturria-Medina Y, Sotero RC, Toussaint PJ et al (2016) Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis. Nat Commun 7:11934","journal-title":"Nat Commun"},{"key":"183_CR87","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","volume":"27","author":"JW Vogel","year":"2021","unstructured":"Vogel JW, Young AL, Oxtoby NP et al (2021) Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease. Nat Med 27:871\u2013881","journal-title":"Nat Med"},{"key":"183_CR88","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/brainsci9090217","volume":"9","author":"H Taheri Gorji","year":"2019","unstructured":"Taheri Gorji H, Kaabouch N (2019) A Deep Learning approach for Diagnosis of Mild Cognitive Impairment Based on MRI Images. Brain Sci 9:217","journal-title":"Brain Sci"},{"key":"183_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2019.116459","volume":"208","author":"M Liu","year":"2020","unstructured":"Liu M, Li F, Yan H et al (2020) A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer\u2019s disease. Neuroimage 208:116459","journal-title":"Neuroimage"},{"key":"183_CR90","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1093\/brain\/awaa137","volume":"143","author":"S Qiu","year":"2020","unstructured":"Qiu S, Joshi PS, Miller MI et al (2020) Development and validation of an interpretable deep learning framework for Alzheimer\u2019s disease classification. Brain 143:1920\u20131933","journal-title":"Brain"},{"key":"183_CR91","doi-asserted-by":"crossref","unstructured":"Varoquaux G, Cheplygina V. Machine learning for medical imaging: methodological failures and recommendations for the future. npj Digital Medicine 2022;5:48.","DOI":"10.1038\/s41746-022-00592-y"},{"key":"183_CR92","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1016\/S2589-7500(20)30292-2","volume":"3","author":"UJ Muehlematter","year":"2021","unstructured":"Muehlematter UJ, Daniore P, Vokinger KN (2021) Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015\u201320): a comparative analysis. The Lancet Digital Health 3:e195\u2013e203","journal-title":"The Lancet Digital Health"},{"key":"183_CR93","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A et al (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396:413\u2013446","journal-title":"Lancet"},{"key":"183_CR94","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","volume":"13","author":"S Norton","year":"2014","unstructured":"Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C (2014) Potential for primary prevention of Alzheimer\u2019s disease: an analysis of population-based data. Lancet Neurol 13:788\u2013794","journal-title":"Lancet Neurol"},{"key":"183_CR95","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/gps.4245","volume":"30","author":"K Deckers","year":"2015","unstructured":"Deckers K, van Boxtel MP, Schiepers OJ et al (2015) Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry 30:234\u2013246","journal-title":"Int J Geriatr Psychiatry"},{"key":"183_CR96","first-page":"0089","volume":"89","author":"V Bellou","year":"2016","unstructured":"Bellou V, Belbasis L, Tzoulaki I, Middleton LT, Ioannidis JP, Evangelou E (2016) Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta-analyses. Alzheimers Dement 89:0089","journal-title":"Alzheimers Dement"},{"key":"183_CR97","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.3233\/JAD-190181","volume":"70","author":"KJ Anstey","year":"2019","unstructured":"Anstey KJ, Ee N, Eramudugolla R, Jagger C, Peters R (2019) A Systematic review of meta-analyses that evaluate risk factors for dementia to evaluate the quantity, quality, and global representativeness of evidence. J Alzheimers Dis 70:S165-s186","journal-title":"J Alzheimers Dis"},{"key":"183_CR98","first-page":"899","volume":"34","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Xu W, Zhang W et al (2021) Modifiable Risk Factors for Incident Dementia and Cognitive Impairment: An Umbrella. Rev Evid 34:899","journal-title":"Rev Evid"},{"key":"183_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2022.112895","volume":"209","author":"KL Parra","year":"2022","unstructured":"Parra KL, Alexander GE, Raichlen DA, Klimentidis YC, Furlong MA (2022) Exposure to air pollution and risk of incident dementia in the UK Biobank. Environ Res 209:112895","journal-title":"Environ Res"},{"key":"183_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2022.107118","volume":"161","author":"J Duchesne","year":"2022","unstructured":"Duchesne J, Gutierrez L-A, Carri\u00e8re I et al (2022) Exposure to ambient air pollution and cognitive decline: Results of the prospective Three-City cohort study. Environ Int 161:107118","journal-title":"Environ Int"},{"key":"183_CR101","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12877-016-0342-y","volume":"16","author":"LOJ Killin","year":"2016","unstructured":"Killin LOJ, Starr JM, Shiue IJ, Russ TC (2016) Environmental risk factors for dementia: a systematic review. BMC Geriatr 16:175","journal-title":"BMC Geriatr"},{"key":"183_CR102","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3233\/JAD-180013","volume":"64","author":"E Ku\u017ama","year":"2018","unstructured":"Ku\u017ama E, Hannon E, Zhou A et al (2018) Which risk factors causally influence dementia? a systematic review of Mendelian randomization studies. J Alzheimers Dis 64:181\u2013193","journal-title":"J Alzheimers Dis"},{"key":"183_CR103","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fgene.2020.00350","volume":"11","author":"HL Nicholls","year":"2020","unstructured":"Nicholls HL, John CR, Watson DS, Munroe PB, Barnes MR, Cabrera CP (2020) Reaching the End-Game for GWAS: Machine Learning Approaches for the Prioritization of Complex Disease Loci. Front Genetics 11:8","journal-title":"Front Genetics"},{"key":"183_CR104","doi-asserted-by":"publisher","first-page":"10351","DOI":"10.1038\/s41598-019-46649-z","volume":"9","author":"A Romagnoni","year":"2019","unstructured":"Romagnoni A, J\u00e9gou S, Van Steen K et al (2019) Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data. Sci Rep 9:10351","journal-title":"Sci Rep"},{"key":"183_CR105","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1093\/bioinformatics\/btac214","volume":"38","author":"L Chen","year":"2022","unstructured":"Chen L, Wang Y, Zhao F (2022) Exploiting deep transfer learning for the prediction of functional non-coding variants using genomic sequence. Bioinformatics 38:3164\u20133172","journal-title":"Bioinformatics"},{"key":"183_CR106","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s42256-020-0197-y","volume":"2","author":"M Prosperi","year":"2020","unstructured":"Prosperi M, Guo Y, Sperrin M et al (2020) Causal inference and counterfactual prediction in machine learning for actionable healthcare. Nature Machine Intelligence 2:369\u2013375","journal-title":"Nature Machine Intelligence"},{"key":"183_CR107","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-022846","volume":"9","author":"R Peters","year":"2019","unstructured":"Peters R, Booth A, Rockwood K, Peters J, D\u2019Este C, Anstey KJ (2019) Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis. BMJ Open 9:e022846","journal-title":"BMJ Open"},{"key":"183_CR108","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.neurobiolaging.2022.02.016","volume":"117","author":"IF Foote","year":"2022","unstructured":"Foote IF, Jacobs BM, Mathlin G et al (2022) The shared genetic architecture of modifiable risk for Alzheimer\u2019s disease: a genomic structural equation modelling study. Neurobiol Aging 117:222\u2013235","journal-title":"Neurobiol Aging"},{"key":"183_CR109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002933","volume":"16","author":"Y Ma","year":"2019","unstructured":"Ma Y, Wolters FJ, Chibnik LB et al (2019) Variation in blood pressure and long-term risk of dementia: A population-based cohort study. PLoS Med 16:e1002933","journal-title":"PLoS Med"},{"key":"183_CR110","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-038753","volume":"10","author":"G Perera","year":"2020","unstructured":"Perera G, Rijnbeek PR, Alexander M et al (2020) Vascular and metabolic risk factor differences prior to dementia diagnosis: a multidatabase case\u2013control study using European electronic health records. BMJ Open 10:e038753","journal-title":"BMJ Open"},{"key":"183_CR111","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1474-4422(19)30228-5","volume":"18","author":"CA Lane","year":"2019","unstructured":"Lane CA, Barnes J, Nicholas JM et al (2019) Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study. Lancet Neurol 18:942\u2013952","journal-title":"Lancet Neurol"},{"key":"183_CR112","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.biopsych.2020.12.015","volume":"89","author":"W Sproviero","year":"2021","unstructured":"Sproviero W, Winchester L, Newby D et al (2021) High blood pressure and risk of dementia: a two-sample Mendelian Randomization Study in the UK Biobank. Biol Psychiatry 89:817\u2013824","journal-title":"Biol Psychiatry"},{"key":"183_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222212","volume":"14","author":"PJ Moore","year":"2019","unstructured":"Moore PJ, Lyons TJ, Gallacher J (2019) Using path signatures to predict a diagnosis of Alzheimer\u2019s disease. PLoS ONE 14:e0222212","journal-title":"PLoS ONE"},{"key":"183_CR114","doi-asserted-by":"publisher","unstructured":"Sindi S, Calov E, Fokkens J, et al. The CAIDE Dementia Risk Score App: The development of an evidence-based mobile application to predict the risk of dementia. Alzheimer's dementia (Amsterdam, Netherlands). 2015;1:328\u2013333. http:\/\/europepmc.org\/abstract\/MED\/27239514; https:\/\/doi.org\/10.1016\/j.dadm.2015.06.005; https:\/\/europepmc.org\/articles\/PMC4878198; https:\/\/europepmc.org\/articles\/PMC4878198?pdf=render. Accessed 2015\/09\/\/.","DOI":"10.1016\/j.dadm.2015.06.005"},{"key":"183_CR115","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1474-4422(06)70537-3","volume":"5","author":"M Kivipelto","year":"2006","unstructured":"Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J (2006) Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet neurol 5:735\u2013741","journal-title":"Lancet neurol"},{"key":"183_CR116","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s42256-020-00276-w","volume":"3","author":"R Liu","year":"2021","unstructured":"Liu R, Wei L, Zhang P (2021) A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data. Nat Mach Intell 3:68\u201375","journal-title":"Nat Mach Intell"},{"key":"183_CR117","doi-asserted-by":"crossref","unstructured":"Fang J, Zhang P, Wang Q, et al. Network-based Translation of GWAS Findings to Pathobiology and Drug Repurposing for Alzheimer\u2019s Disease. medRxiv 2020:2020.2001.2015.20017160.","DOI":"10.1101\/2020.01.15.20017160"},{"key":"183_CR118","first-page":"6","volume":"89","author":"J Xu","year":"2021","unstructured":"Xu J, Zhang P, Huang Y et al (2021) Multimodal single-cell\/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer\u2019s disease. Genome Res 89:6","journal-title":"Genome Res"},{"key":"183_CR119","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12539-021-00487-8","volume":"14","author":"F Yang","year":"2022","unstructured":"Yang F, Zhang Q, Ji X et al (2022) Machine Learning Applications in Drug Repurposing. Interdiscip Sci 14:15\u201321","journal-title":"Interdiscip Sci"},{"key":"183_CR120","doi-asserted-by":"publisher","unstructured":"Rodriguez S, Hug C, Todorov P, et al. Machine learning identifies candidates for drug repurposing in Alzheimer's disease. Nature commun. 2021;12:1033. http:\/\/europepmc.org\/abstract\/MED\/33589615; https:\/\/doi.org\/10.1038\/s41467-021-21330-0; https:\/\/europepmc.org\/articles\/PMC7884393; https:\/\/europepmc.org\/articles\/PMC7884393?pdf=render. Accessed Feb 2021.","DOI":"10.1038\/s41467-021-21330-0"},{"key":"183_CR121","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13195-021-00826-3","volume":"13","author":"S Tsuji","year":"2021","unstructured":"Tsuji S, Hase T, Yachie-Kinoshita A et al (2021) Artificial intelligence-based computational framework for drug-target prioritization and inference of novel repositionable drugs for Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther 13:92","journal-title":"Alzheimer's Res Ther"},{"key":"183_CR122","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/ebmental-2019-300118","volume":"23","author":"A Tomlinson","year":"2020","unstructured":"Tomlinson A, Furukawa TA, Efthimiou O et al (2020) Personalise antidepressant treatment for unipolar depression combining individual choices, risks and big data (PETRUSHKA): rationale and protocol. Evid Based Ment Health 23:52\u201356","journal-title":"Evid Based Ment Health"},{"key":"183_CR123","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12916-022-02250-2","volume":"20","author":"Q Liu","year":"2022","unstructured":"Liu Q, Vaci N, Koychev I et al (2022) Personalised treatment for cognitive impairment in dementia: development and validation of an artificial intelligence model. BMC Med 20:45","journal-title":"BMC Med"},{"key":"183_CR124","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.aat8464","volume":"362","author":"D Wang","year":"2018","unstructured":"Wang D, Liu S, Warrell J et al (2018) Comprehensive functional genomic resource and integrative model for the human brain. Science 362:89","journal-title":"Science"},{"key":"183_CR125","unstructured":"Institute\" UDR. A Multi-'omics Atlas Project - Alzheimer's Disease A UK DRI Director's Initiative. https:\/\/map-ad.org\/."},{"key":"183_CR126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000245","volume":"7","author":"HB van der Worp","year":"2010","unstructured":"van der Worp HB, Howells DW, Sena ES et al (2010) Can animal models of disease reliably inform human studies? PLoS Med 7:e1000245","journal-title":"PLoS Med"},{"key":"183_CR127","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1084\/jem.20182042","volume":"215","author":"RM Ransohoff","year":"2018","unstructured":"Ransohoff RM (2018) All (animal) models (of neurodegeneration) are wrongAre they also useful? J Exp Med 215:2955\u20132958","journal-title":"J Exp Med"},{"key":"183_CR128","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41587-021-01001-7","volume":"40","author":"M Lotfollahi","year":"2022","unstructured":"Lotfollahi M, Naghipourfar M, Luecken MD et al (2022) Mapping single-cell data to reference atlases by transfer learning. Nat Biotechnol 40:121\u2013130","journal-title":"Nat Biotechnol"},{"key":"183_CR129","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s41592-018-0214-9","volume":"15","author":"R Normand","year":"2018","unstructured":"Normand R, Du W, Briller M et al (2018) Found In Translation: a machine learning model for mouse-to-human inference. Nat Methods 15:1067\u20131073","journal-title":"Nat Methods"},{"key":"183_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101665","volume":"53","author":"J You","year":"2022","unstructured":"You J, Zhang YR, Wang HF et al (2022) Development of a novel dementia risk prediction model in the general population: A large, longitudinal, population-based machine-learning study. EClinicalMedicine 53:101665","journal-title":"EClinicalMedicine"}],"container-title":["Brain Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40708-022-00183-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40708-022-00183-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40708-022-00183-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T03:53:52Z","timestamp":1728964432000},"score":1,"resource":{"primary":{"URL":"https:\/\/braininformatics.springeropen.com\/articles\/10.1186\/s40708-022-00183-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":130,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["183"],"URL":"https:\/\/doi.org\/10.1186\/s40708-022-00183-3","relation":{},"ISSN":["2198-4018","2198-4026"],"issn-type":[{"value":"2198-4018","type":"print"},{"value":"2198-4026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]},"assertion":[{"value":"31 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AK declares research grant funding from GlaxoSmithKline. All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}